Quantinno Capital Management LP Has $48.69 Million Holdings in Synopsys, Inc. $SNPS

Quantinno Capital Management LP lifted its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 114.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 122,800 shares of the semiconductor company’s stock after acquiring an additional 65,494 shares during the quarter. Quantinno Capital Management LP owned approximately 0.06% of Synopsys worth $48,688,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Sankala Group LLC bought a new position in Synopsys in the fourth quarter valued at about $25,000. Thurston Springer Miller Herd & Titak Inc. bought a new stake in shares of Synopsys during the fourth quarter worth about $28,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Synopsys in the fourth quarter valued at approximately $28,000. Atlas Capital Advisors Inc. bought a new position in Synopsys in the 4th quarter valued at approximately $32,000. Finally, Geneos Wealth Management Inc. raised its holdings in Synopsys by 151.5% in the 1st quarter. Geneos Wealth Management Inc. now owns 83 shares of the semiconductor company’s stock valued at $33,000 after buying an additional 50 shares during the last quarter. Institutional investors own 85.47% of the company’s stock.

Trending Headlines about Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Expanded Nvidia partnership supports AI growth. Nvidia is adding Synopsys to its Agent Toolkit ecosystem, helping automate chip and system design. The relationship could increase demand for Synopsys’ electronic design automation (EDA) software as semiconductor companies adopt agentic AI. Agentic AI Is Coming to Chip Design. Here Is Why Synopsys Stock Could Be the Biggest Beneficiary
• Positive Sentiment: AI alliances may strengthen Synopsys’ strategic position. Partnerships involving Nvidia, AMD, Microsoft and Intel are aimed at automating chip-design bottlenecks, potentially improving productivity for customers and reinforcing Synopsys’ central role in the semiconductor ecosystem. Synopsys Just Solved a Bottleneck You Didn’t Even Know Existed
• Positive Sentiment: Intel’s next-generation 14A process provides another validation point. Synopsys’ tools are already supporting Intel’s 14A chip-development efforts, highlighting the importance of its software in advanced semiconductor manufacturing. Intel’s 14A chips aren’t built yet: Synopsys is already there
• Neutral Sentiment: Recent results remain solid but acquisition-driven. Quarterly revenue rose 41.9% year over year to $2.28 billion and EPS exceeded expectations, largely reflecting the Ansys acquisition. Investors may be looking for stronger organic growth to support Synopsys’ premium valuation. Synopsys: How Agentic AI And Ansys Drive Long-Term Growth
• Negative Sentiment: The immediate decline appears tied more to market and valuation pressure than a new fundamental setback. Reports noted that Synopsys underperformed the broader market during the latest session, while its elevated earnings multiple and recent underperformance likely encouraged caution and profit-taking. No new earnings warning was cited. Here’s Why Synopsys Fell More Than Broader Market

Insider Transactions at Synopsys

In other Synopsys news, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the stock. Morgan Stanley boosted their target price on shares of Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a report on Thursday, May 28th. Zacks Research upgraded shares of Synopsys from a “hold” rating to a “strong-buy” rating in a report on Tuesday, June 30th. Piper Sandler raised shares of Synopsys from a “neutral” rating to an “overweight” rating and boosted their price objective for the stock from $450.00 to $550.00 in a research note on Tuesday, June 23rd. Berenberg Bank set a $633.00 price objective on Synopsys in a report on Wednesday, May 27th. Finally, Robert W. Baird set a $558.00 target price on Synopsys in a research report on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Synopsys has an average rating of “Moderate Buy” and an average price target of $570.06.

Synopsys Stock Down 2.6%

Shares of NASDAQ SNPS opened at $373.69 on Thursday. The company’s 50 day moving average price is $449.23 and its 200-day moving average price is $452.19. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. Synopsys, Inc. has a 52-week low of $366.00 and a 52-week high of $651.73. The company has a market capitalization of $71.55 billion, a P/E ratio of 86.50, a price-to-earnings-growth ratio of 2.25 and a beta of 1.22.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion during the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. Synopsys’s quarterly revenue was up 41.9% on a year-over-year basis. During the same quarter last year, the firm earned $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities analysts forecast that Synopsys, Inc. will post 10.65 earnings per share for the current year.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.